Eva Madrid, the Lead of Cochrane’s new Iberoamérica Evidence Synthesis Unit, spoke on the panel of the launch event for the ...

Dr. Barry Davies joins Mosaic Therapeutics as CSO, bringing 25 years of drug discovery expertise to advance targeted oncology therapies and precision medicine.

Significant investments in digital health, telemedicine, and Artificial Intelligence (AI)-driven diagnostics have reshaped ...

The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until ...

The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until ...

Broadening global laboratory services for clinical research To serve pharma and biotech customers with advanced laboratory services and leading-edge instrumentation across all phases of pharmaceutical ...

Researchers describe the mechanisms of how alterations in the CDK12 gene drive prostate cancer development and report on a promising degrader that targets CDK12 and a related gene to destroy tumors.

In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation more ...

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease ...

Avera participates in numerous clinical trials, including ones that are Phase 1. In this Avera Medical Minute, we share what ...